Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.50
-0.47 (-1.47%)
At close: Sep 18, 2026, 4:00 PM EDT
32.13
+0.63 (2.00%)
After-hours: Sep 18, 2026, 7:45 PM EDT
Zenas BioPharma Employees
Zenas BioPharma had 167 employees as of December 31, 2025. The number of employees increased by 37 or 28.46% compared to the previous year.
Employees
167
Change (1Y)
37
Growth (1Y)
28.46%
Revenue / Employee
$5,988
Profits / Employee
-$2,900,503
Market Cap
2.05B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 167 | 37 | 28.46% |
| Dec 31, 2024 | 130 | 23 | 21.50% |
| Sep 30, 2024 | 115 | 31 | 36.90% |
| Jun 30, 2024 | 114 | 30 | 35.71% |
| Mar 31, 2024 | 107 | - | - |
| Sep 30, 2023 | 84 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| ADMA Biologics | 647 |
| Recursion Pharmaceuticals | 600 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Nuvation Bio | 305 |
| UroGen Pharma | 300 |
| Biohaven | 274 |
ZBIO News
- 1 day ago - Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - Zenas BioPharma Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 days ago - Zenas BioPharma Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 8 days ago - Zenas BioPharma files to sell 7.0M shares of common stock for holders - TheFly
- 10 days ago - Zenas BioPharma Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 12 days ago - Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event - GlobeNewsWire
- 12 days ago - Zenas BioPharma Slides: Corporate presentation - Filings
- 16 days ago - Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire